Notice Number: NOT-HL-09-129
Release Date: October 16, 2009
National Heart, Lung and Blood Institute (NHLBI) (www.nhlbi.nih.gov)
The National Heart, Lung, and Blood Institute (NHLBI) intends to issue a Request for Applications (RFA) to solicit applications for the Innovators in Hemoglobinopathies Career Development Award (K07). The goal of this initiative will be to foster the research career development of clinical scientists who have developed and implemented innovative programs for patients with sickle cell disease and/or the thalassemias. The purpose of this K07 Program is to develop clinical research capacity in hemoglobinopathies by enabling new and early stage investigators to participate in the design and conduct of high-quality, multicenter and multidisciplinary studies that address important questions about patient management and the translation of research results into practice. Candidates for this award would not be eligible for one of the other NHLBI mentored career development awards, i.e., K23, K01, or K08 http://www.nhlbi.nih.gov/funding/training/redbook/newintro.htm.
This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The RFA is expected to be published in Fall 2009 with an expected receipt date in January 2010.
This RFA will utilize the K07 grant mechanism.
APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.
Interested parties may contact:
Ellen M. Werner, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Room 9162
Bethesda MD 20892-7950
Bethesda, MD 20817 (for courier service)
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.